1. Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma. Issue 3 (19th August 2014) Authors: Reardon, David A.; Nabors, Louis B.; Mason, Warren P.; Perry, James R.; Shapiro, William; Kavan, Petr; Mathieu, David; Phuphanich, Surasak; Cseh, Agnieszka; Fu, Yali; Cong, Julie; Wind, Sven; Eisenstat, David D.; Reardon, David; Wen, Patrick; Mikkelson, Tom; Portnow, Jana; Giglio, Pierre; Lai, Ro... Journal: Neuro-oncology Issue: Volume 17:Issue 3(2015:Mar.) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗